Fig. 3
Outcomes of AITL patients based on the disease status at allo-HCT. a Cumulative incidence of non-relapse mortality. b Cumulative incidence of lymphoma progression/relapse. c Progression-free survival. d Overall survival
Fig. 3 | Journal of Hematology & Oncology